No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

Published Date: 30 Sep 2024

Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

2.

Two-part prodrug system activates immune attack only in tumor's unique environment

3.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Glofitamab Regimen Improves Survival in DLBCL


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot